Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Minwell

Diagnostic Radiology Knoxville, TN Medical Doctor

NPI 1528334281 CMS profile 1395151

1924 Alcoa Hwy, Knoxville, TN 37920

Open in the dashboard

General payments

$104,835

194 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Minwell of Knoxville, TN is reported in the CMS Open Payments database as having received $104,835 across 194 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,592 41
2024 General $54,263 61
2023 General $13,694 27
2022 General $5,071 13
2021 General $10,759 12
2020 General $266 3
2019 General $4,189 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Minwell
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Gregory Minwell were reported at $16,592. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Gregory Minwell Diagnostic Radiology median Middle half National median
2019 $4,189 $108 $29–$318 $163
2020 $266 $65 $21–$252 $114
2021 $10,759 $92 $24–$292 $132
2022 $5,071 $104 $29–$294 $149
2023 $13,694 $110 $29–$337 $160
2024 $54,263 $113 $30–$356 $164
2025 $16,592 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $89,578 122 payments
  2. FUJIFILM Corporation $7,000 1 payment
  3. Sirtex Medical Inc $3,054 17 payments
  4. Penumbra, Inc. $2,016 7 payments
  5. Biocompatibles, Inc. $1,119 10 payments
  6. Inari Medical, Inc. $940 16 payments
  7. Surefire Medical, Inc. $392 3 payments
  8. Medtronic, Inc. $260 4 payments
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $126 3 payments
  10. Stryker Corporation $85 1 payment
  11. Other $263 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $76,050 54 payments
  2. Travel and Lodging $14,093 36 payments
  3. Food and Beverage $7,692 103 payments
  4. Consulting Fee $7,000 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $56,363 53 payments
  2. TheraSphere Y90 Glass Microspheres 10 GBq $19,970 38 payments
  3. Synapse 3D $7,000 1 payment
  4. GENERAL PAIN MANAGEMENT $6,000 4 payments
  5. TheraSphere $4,500 6 payments
  6. Indigo $3,029 7 payments
  7. LAVA LES (Liquid Embolic System) $2,046 7 payments
  8. SIR-Spheres Microspheres $1,008 10 payments
  9. THERASPHERE - BIO $949 2 payments
  10. FLOWTRIEVER CATHETER, S $831 12 payments
  11. Other $3,312 72 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 176 billing codes

Paid by Medicare

$86,318

Medicare's payments for the services billed

Medicare patients

1,067

Average age 74

Services billed

2,006

532 women, 535 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 43%
Diabetes 39%
Chronic kidney disease 37%
Atrial fibrillation 33%
Depression 33%
Heart failure 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

194 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record